 |
市场调查报告书
商品编码
1594230
全球基因编辑市场：按产品、服务、技术、技术、应用分类 - 预测（~2029 年）Gene Editing Market by Product, Services, Technique, Technology, Application -Global Forecast to 2029 |
||||||
价格
全球基因编辑市场规模预计将从 2024 年的 46.6 亿美元增至 2029 年的 75.9 亿美元，预测期内复合年增长率为 10.2%。
| 调查范围 | |
|---|---|
| 调查年份 | 2022-2029 |
| 基准年 | 2023年 |
| 预测期 | 2024-2029 |
| 单元 | 100万美元 |
| 部分 | 产品、服务、製程、技术、用途 |
| 目标区域 | 北美、欧洲、亚太地区、拉丁美洲、中东/非洲 |
基因编辑技术的进步和基因编辑用途的扩大等因素正在推动基因编辑市场的成长。然而，由于基因编辑的脱靶效应，它面临多重挑战，再加上可扩展性和製造困难，构成了重大障碍。
“通过提供，该产品细分市场将在 2023 年占据基因编辑市场的最大份额。”
基因编辑过程中对产品的需求，包括细胞株开发的实验和研究、药物开发和发现，已成为遗传学市场的关键。基因编辑产品，如试剂、耗材和软体系统，如基因编辑试剂套件、基因编辑试剂和基因编辑文库，被製药和生物技术公司以及学术和研究机构用于各种基因编辑工作流程。该服务在 2023 年占据基因编辑市场第二高的份额。
“从技术上看，2023年基因编辑产品市场中，CRISPR技术占据最高市场占有率。”
由于CRISPR技术的进步导致该技术在基因编辑中的大规模采用，到2023年，按技术划分，CRISPR细分市场将占据基因编辑产品市场的最高份额。基因编辑产品广泛用于 CRISPR 应用，包括 Cas-9 等试剂、载体、用于筛检和靶点识别的文库以及基于 CRISPR 的基因编辑试剂套件。儘管如此，TALEN 细分市场到 2023 年仍将占据第二大市场。
“从 2024 年到 2029 年，亚太地区基因编辑市场的复合年增长率将达到最高。”
由于对基因编辑研究的研发活动、政府和私营部门的资助以及在药物发现和开发中越来越多地采用基因编辑技术，亚太地区是市场中成长最快的部分。此外，罕见疾病和遗传病患疾病的上升是由于日本和中国等国家的人口老化所致。这正在推动基因编辑技术在健康管理和治疗中的采用，从而推动市场成长。然而，到2023年，北美将占据基因编辑市场的最大份额。
本报告研究和分析了全球基因编辑市场，提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。
目录
第一章简介
第二章调查方法
第三章执行摘要
第 4 章重要考察
- 基因编辑市场概况
- 北美基因编辑市场：按类型、国家划分（2023 年）
- 基因编辑市场：地理成长机会
第五章市场概况
- 介绍
- 市场动态
- 促进因素
- 抑制因素
- 机会
- 任务
- 影响客户业务的趋势/干扰
- 价格分析
- 主要企业平均销售价格趋势：依消耗品分类（2023年）
- 基因编辑套件和试剂的平均成本范围（2021-2023）
- 服务平均售价趋势：按类型
- 平均售价：按地区
- 供应链分析
- 价值链分析
- 生态系分析
- 产生人工智慧对基因编辑市场的影响
- 技术分析
- 主要技术
- 互补技术
- 邻近技术
- 专利分析
- 重大会议和活动（2024-2025）
- 监管分析
- 监管环境
- 监管机构、政府机构和其他组织
- 波特五力分析
- 主要相关利益者和采购标准
- 案例研究分析
- 投资金筹措场景
- 贸易资料分析
- 进口资料（2019-2023）
- 出口资料（2019-2023）
第六章 基因编辑市场：副产品
- 介绍
- 产品
- 服务
第七章基因编辑产品市场：依类型
- 介绍
- 试剂/耗材
- 基因编辑套件
- 基因编辑库
- 基因编辑试剂
- 软体系统
第八章基因编辑试剂及耗材市场：依技术分类
- 介绍
- 昏死
- 敲门
- 基因静默
- 其他技术
第九章基因编辑产品市场：依技术分类
- 介绍
- CRISPR
- TALEN
- ZFN
- 碱基编辑
- 反义
- RNAI
- 其他技术
第10章基因编辑产品市场：依应用分类
- 介绍
- 细胞株工程
- 基因组编辑
- 药物发现/开发
- 其他用途
第十一章 基因编辑产品市场：依最终使用者分类
- 介绍
- 製药和生物技术公司
- 学术/研究机构
- CRO・CDMO
- 其他最终用户
第十二章基因编辑服务市场：依类型
- 介绍
- 细胞株开发/工程
- GRNA合成/载体构建
- 文库建置/筛检
- 其他服务
第十三章基因编辑服务市场：依应用分类
- 介绍
- 细胞株工程
- 基因组编辑
- 药物发现/开发
- 其他用途
第 14 章 基因编辑服务市场：依最终使用者分类
- 介绍
- 製药和生物技术公司
- 学术/研究机构
- 其他最终用户
第十五章 基因编辑市场：按地区
- 介绍
- 北美洲
- 北美宏观经济展望
- 美国
- 加拿大
- 欧洲
- 欧洲宏观经济展望
- 德国
- 法国
- 英国
- 义大利
- 西班牙
- 欧洲其他地区
- 亚太地区
- 亚太宏观经济展望
- 中国
- 日本
- 印度
- 韩国
- 澳洲
- 其他亚太地区
- 拉丁美洲
- 拉丁美洲宏观经济展望
- 巴西
- 其他拉丁美洲
- 中东
- 中东宏观经济展望
- 海湾合作委员会国家
- 其他中东地区
- 非洲
第十六章竞争格局
- 介绍
- 主要企业策略/主要企业（2021-2024）
- 收益分析（2019-2023）
- 市场占有率分析（2023）
- 公司评价及财务指标
- 公司评价
- 财务指标
- 品牌/产品比较
- 赛默飞世尔科技有限公司（美国）
- 默克集团（德国）
- GENSCRIPT（美国）
- 安捷伦科技有限公司（美国）
- REVVITY, INC.（美国）
- 企业评价矩阵：主要企业（2023年）
- 企业评估矩阵：Start-Ups/中小企业（2023）
- 竞争场景
第十七章 公司简介
- 主要企业
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGAA
- GENSCRIPT
- AGILENT TECHNOLOGIES, INC.
- REVVITY, INC.
- LONZA
- TECAN TRADING AG
- SANGAMO THERAPEUTICS
- PRECISION BIOSCIENCES
- CELLECTIS SA
- REGENERON PHARMACEUTICALS, INC.
- AMSBIO
- CREATIVE BIOGENE
- SYNTHEGO
- TAKARA BIO INC.
- BIO-TECHNE
- CARIBOU BIOSCIENCES, INC.
- BIONEER CORPORATION
- REPROCELL INC.
- 其他公司
- ALSTEM INC.
- NEW ENGLAND BIOLABS
- INSCRIPTA, INC.
- BIOCAT GMBH.
- INTEGRATED DNA TECHNOLOGIES, INC.
- COBO TECHNOLOGIES APS
- GENECOPOEIA, INC.
- HERA BIOLABS
- STEMCELL TECHNOLOGIES.
- AXOL BIOSCIENCE LTD.
- CELLECTA, INC.
- APPLIED STEMCELL
第十八章附录
Product Code: BT 3380
The gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2% during the forecast period.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2022-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD Million) |
| Segments | by Product, Services, Technique, Technology, Application |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Factors such as advancements in gene editing technologies, and the expanding range of gene editing applications are driving the growth of the gene editing market. However, the market faces several challenges due to off-target effects of gene editing, along with difficulties in scalability and manufacturing, pose significant hurdles.
"The product segment accounted for the largest share by offerings segment in the gene editing market in 2023"
By offerings, the gene editing market is segmented into products and services. The products segment held the largest share in 2023. The demand for products in gene editing process including experimentation and research for cell line development and drug development & discovery make them an indispensable part of the gene market. Gene editing products as reagents & consumables and Software & systems like gene editing kits, gene editing reagents and gene editing libraries are utilized by pharmaceutican & biotechnology companies and academic & research institutes in various gene editing workflow. Services held the second highest share of the gene editing market in 2023.
"The CRISPR technology held the highest market share of the gene editing products market by technology in 2023"
By Technology, the gene editing products market is segmented into CRISPR, TALEN, ZFN, Base editing, Antisense, RNAi and other technologies which include piggybac and prime editing among others. The CRISPR segment held the highest share of the gene editing products by technology market in 2023 driven by advancements in CRISPR technology leading to large scale adoption of this technology in gene editing. Gene editing products are used in a large range of CRISPR applications including reagents like Cas-9, vectors, libraries for screening and target identification and CRISPR based gene editing kits. Still, TALEN segment held the second largest share of the market in 2023.
"The Asia Pacific region is growing at the highest CAGR in the gene editing market from 2024 to 2029."
The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the a significant focus on R&D activities, funding by government and private players in gene editing research, and rising adoption of gene editing technologies in drug discovery & development. Further, the rising prevalence of rare and genetic diseases is attributed to the aging population of countries such as Japan, and China. This is supporting the adoption of gene editing technologies in healthcare management and treatment driving the market growth. However, North America held the largest share of gene editing market in 2023.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70% and Demand Side 30%
- By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
- By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.
List of Companies Profiled in the Report:
- Thermo fisher scientific Inc. (US)
- Merck KGaA (Germany)
- GenScript (US)
- Agilent Technologies, Inc. (US)
- Revvity (US)
- Lonza (US)
- Tecan Trading AG (Switzerland)
- Sangamo therapeutics (US)
- Precision BioSciences (US)
- Cellectis S.A. (France)
- Regeneron Pharmaceuticals Inc. (US)
- AMSBIO (UK)
- Creative Biogene (US)
- Synthego (US)
- Takara Bio Inc. (Japan)
- Bio-Techne (US)
- Caribou Biosciences, Inc. (US)
- Bioneer corporation (South Korea)
- REPROCELL Inc. (Japan)
Research Coverage:
This research report categorizes the gene editing market by offerings (products and services), products by type (reagnets & consumables, and software & systems), reagents & consumables by Technique (knock-out, knock-in, gene silencing, and other techniques), products by technology (CRISPR, TALEN, ZFN, Base editing, Antisense, RNAi and other technologies), products by application (cell line engineering, genome editing/genetic engineering, drug discovery & development, and other applications), products by end user (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs, and other end users), services by type (cell line engineering, gRNA synthesis & vector construction, library construction & screening, and other types), services by application (cell line development & engineering, genome editing/genetic engineering, drug discovery & development, and other applications), services by end user (pharmaceutical & biotechnology companies, academic & research institutes, and other end users) and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the genomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product & service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the gene editing market. Competitive analysis of top players and upcoming startups in the gene editing market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall gene editing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Increasing demand for personalized medicine, Favorable government funding investments for gene editing projects, Expanding applications of gene editing), restraints (Off-Target Effects and Safety Concerns), opportunities (Technological advancements in Prime editing and bridge RNA, Rising burden of congenital disorders), and challenges (Issues with scalability of gene editing workflows. High equipment and facility costs) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched product/services of the gene editing market
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the gene editing market
- Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), GenScript (US), Agilent Technologies, Inc. (US), Revvity (US), Lonza (US), Tecan Trading AG (Switzerland), Sangamo therapeutics (US). Precision BioSciences (US), Cellectis S.A. (France), Regeneron Pharmaceuticals Inc. (US), AMSBIO (UK), Creative Biogene (US), Synthego (US), Takara Bio Inc. (Japan), Bio-Techne (US), Caribou Biosciences, Inc. (US) Bioneer corporation (South Korea), and REPROCELL Inc. (Japan).
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.4 LIMITATIONS
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
- 2.2 MARKET ESTIMATION METHODOLOGY
- 2.2.1 MARKET ESTIMATION
- 2.2.1.1 Insights of primary experts
- 2.2.2 SEGMENTAL MARKET SIZE ESTIMATIONS
- 2.2.1 MARKET ESTIMATION
- 2.3 MARKET GROWTH RATE PROJECTIONS
- 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.5 RESEARCH ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 GENE EDITING MARKET OVERVIEW
- 4.2 NORTH AMERICA: GENE EDITING MARKET, BY TYPE AND COUNTRY (2023)
- 4.3 GENE EDITING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Increasing demand for personalized medicine
- 5.2.1.2 Favorable government funding investments for gene editing projects
- 5.2.1.3 Expanding applications of gene editing
- 5.2.2 RESTRAINTS
- 5.2.2.1 Off-target effects and safety concerns
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Rising technological advancements in prime editing and bridge RNA
- 5.2.3.2 Increasing burden of congenital disorders
- 5.2.4 CHALLENGES
- 5.2.4.1 Issues associated with scalability of gene editing workflows
- 5.2.4.2 High equipment & manufacturing costs
- 5.2.1 DRIVERS
- 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY CONSUMABLE (2023)
- 5.4.2 AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021-2023
- 5.4.3 AVERAGE SELLING PRICE TREND OF SERVICES, BY TYPE
- 5.4.4 AVERAGE SELLING PRICE, BY REGION
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 VALUE CHAIN ANALYSIS
- 5.7 ECOSYSTEM ANALYSIS
- 5.8 IMPACT OF GENERATIVE AI ON GENE EDITING MARKET
- 5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
- 5.9.1.1 Next-generation sequencing
- 5.9.1.2 Electroporation
- 5.9.1.3 Microinjection
- 5.9.2 COMPLEMENTARY TECHNOLOGIES
- 5.9.2.1 Synthetic biology
- 5.9.2.2 Data analysis
- 5.9.2.3 High-throughput screening
- 5.9.3 ADJACENT TECHNOLOGIES
- 5.9.3.1 Single-cell analysis
- 5.9.3.2 Optogenetics
- 5.9.3.3 Gene delivery systems
- 5.9.1 KEY TECHNOLOGIES
- 5.10 PATENT ANALYSIS
- 5.11 KEY CONFERENCES AND EVENTS, 2024-2025
- 5.12 REGULATORY ANALYSIS
- 5.12.1 REGULATORY LANDSCAPE
- 5.12.1.1 North America
- 5.12.1.1.1 US
- 5.12.1.1.2 Canada
- 5.12.1.2 Europe
- 5.12.1.2.1 UK
- 5.12.1.3 Asia Pacific
- 5.12.1.3.1 China
- 5.12.1.3.2 Japan
- 5.12.1.3.3 South Korea
- 5.12.1.3.4 Australia
- 5.12.1.3.5 Rest of Asia Pacific
- 5.12.1.1 North America
- 5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.12.1 REGULATORY LANDSCAPE
- 5.13 PORTER'S FIVE FORCES ANALYSIS
- 5.13.1 THREAT OF NEW ENTRANTS
- 5.13.2 THREAT OF SUBSTITUTES
- 5.13.3 BARGAINING POWER OF BUYERS
- 5.13.4 BARGAINING POWER OF SUPPLIERS
- 5.13.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.14.2 KEY BUYING CRITERIA
- 5.15 CASE STUDY ANALYSIS
- 5.15.1 ENHANCED GENE KNOCK-IN EFFICIENCY USING HYBRID SSDNA HDR TEMPLATES IN PRIMARY HUMAN T-CELLS
- 5.15.2 GENE EDITING EFFICIENCY IN CANCER CELL LINES AND T-CELLS USING TRUECUT CAS9 PROTEIN V2 AND TRUEGUIDE SGRNA
- 5.15.3 DEVELOPMENT & SPECIFICITY OPTIMIZATION OF PUREDIT CRISPR CAS9 RNP SYSTEM
- 5.15.4 EVALUATION OF SUREGUIDE CAS9 PROGRAMMABLE NUCLEASE KIT FOR EFFICIENT IN VITRO GENE EDITING
- 5.15.5 GENE EDITING FOR SICKLE-CELL DISEASE USING ZINC FINGER NUCLEASE-MODIFIED HEMATOPOIETIC STEM CELLS
- 5.16 INVESTMENT & FUNDING SCENARIO
- 5.16.1 KEY INVESTMENTS & FUNDING ACTIVITIES, 2021-2024
- 5.17 TRADE DATA ANALYSIS
- 5.17.1 IMPORT DATA, 2019-2023
- 5.17.2 EXPORT DATA, 2019-2023
6 GENE EDITING MARKET, BY OFFERING
- 6.1 INTRODUCTION
- 6.2 PRODUCTS
- 6.2.1 EXPANDING APPLICATIONS OF GENE MODIFICATION TECHNIQUES TO DRIVE MARKET
- 6.3 SERVICES
- 6.3.1 HIGH UPTAKE BY PHARMA COMPANIES FOR DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET
7 GENE EDITING PRODUCTS MARKET, BY TYPE
- 7.1 INTRODUCTION
- 7.2 REAGENTS & CONSUMABLES
- 7.2.1 GENE EDITING KITS
- 7.2.1.1 Increasing demand for mutation & screening kits in clinical settings to propel market
- 7.2.2 GENE EDITING LIBRARIES
- 7.2.2.1 Genetic screening for cancer research to fuel uptake
- 7.2.3 GENE EDITING REAGENTS
- 7.2.3.1 Ability to create animal models to support market growth
- 7.2.1 GENE EDITING KITS
- 7.3 SOFTWARE & SYSTEMS
- 7.3.1 INTEGRATION OF CLOUD-BASED PLATFORMS FOR NGS TO DRIVE MARKET
8 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE
- 8.1 INTRODUCTION
- 8.2 KNOCK-OUT
- 8.2.1 MODIFICATION OF CRISPR-CAS9 AND TALENS TO PROPEL MARKET
- 8.3 KNOCK-IN
- 8.3.1 UTILIZATION OF DONOR DNA TEMPLATES AND HDR PATHWAYS TO DRIVE MARKET
- 8.4 GENE SILENCING
- 8.4.1 ADVANCEMENTS IN RNAI TECHNOLOGY AND ANTISENSE THERAPY TO SUPPORT MARKET GROWTH
- 8.5 OTHER TECHNIQUES
9 GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY
- 9.1 INTRODUCTION
- 9.2 CRISPR
- 9.2.1 ADVANCEMENTS IN CAS9 PROTEINS TO FUEL UPTAKE
- 9.3 TALENS
- 9.3.1 INCREASING DEMAND FOR THERAPEUTIC DEVELOPMENT TO DRIVE MARKET
- 9.4 ZFN
- 9.4.1 PROVISION OF CUSTOMIZED DESIGN AND TARGETED EDITS TO BOOST DEMAND
- 9.5 BASE EDITING
- 9.5.1 GROWING APPLICATIONS IN FUNCTIONAL GENOMICS TO FUEL MARKET
- 9.6 ANTISENSE
- 9.6.1 INNOVATIONS IN OLIGONUCLEOTIDE THERAPIES TO SUPPORT MARKET GROWTH
- 9.7 RNAI
- 9.7.1 WIDE APPLICATIONS IN DRUG DISCOVERY TO FUEL UPTAKE
- 9.8 OTHER TECHNOLOGIES
10 GENE EDITING PRODUCTS MARKET, BY APPLICATION
- 10.1 INTRODUCTION
- 10.2 CELL LINE ENGINEERING
- 10.2.1 ABILITY TO PROVIDE PRECISE GENE MODIFICATIONS FOR VALIDATION TO DRIVE MARKET
- 10.3 GENOME EDITING
- 10.3.1 GROWING APPLICATIONS IN BIOTECHNOLOGY TO BOOST DEMAND
- 10.4 DRUG DISCOVERY & DEVELOPMENT
- 10.4.1 UPTAKE OF CRISPR-BASED SYSTEMS FOR DISEASE PROFILING TO DRIVE MARKET
- 10.5 OTHER APPLICATIONS
11 GENE EDITING PRODUCTS MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 11.2.1 INCREASING PRODUCT APPROVALS AND ROBUST CLINICAL PIPELINE TO PROPEL MARKET
- 11.3 ACADEMIC & RESEARCH INSTITUTES
- 11.3.1 FAVORABLE FUNDING FOR GENOMIC PROJECTS TO DRIVE MARKET
- 11.4 CROS & CDMOS
- 11.4.1 PROVISION OF SPECIALIZED EXPERTISE FOR CLINICAL TRIALS TO DRIVE MARKET
- 11.5 OTHER END USERS
12 GENE EDITING SERVICES MARKET, BY TYPE
- 12.1 INTRODUCTION
- 12.2 CELL LINE DEVELOPMENT & ENGINEERING
- 12.2.1 GROWING DEMAND FOR BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET
- 12.3 GRNA SYNTHESIS & VECTOR CONSTRUCTION
- 12.3.1 ADVANCEMENTS IN GENE EDITING TECHNOLOGIES AND DEMAND FOR PRECISE TARGETING TO DRIVE MARKET
- 12.4 LIBRARY CONSTRUCTION & SCREENING
- 12.4.1 INCREASING FOCUS ON HIGH-THROUGHPUT SCREENING TO PROPEL MARKET
- 12.5 OTHER SERVICES
- 12.5.1 OTHER SERVICES INCLUDE OFF-TARGET ANALYSIS AND MUTAGENESIS SERVICES.
13 GENE EDITING SERVICES MARKET, BY APPLICATION
- 13.1 INTRODUCTION
- 13.2 CELL LINE ENGINEERING
- 13.2.1 HIGH UPTAKE IN R&D FOR THERAPEUTIC BIOPRODUCTION TO DRIVE MARKET
- 13.3 GENOME EDITING
- 13.3.1 GROWING FOCUS ON SYNTHETIC GENOMICS TO BOOST DEMAND
- 13.4 DRUG DISCOVERY & DEVELOPMENT
- 13.4.1 GROWING DEMAND FOR PHARMACEUTICAL DEVELOPMENT TO FUEL UPTAKE
- 13.5 OTHER APPLICATIONS
14 GENE EDITING SERVICES MARKET, BY END USER
- 14.1 INTRODUCTION
- 14.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 14.2.1 GROWING DEMAND FOR ADVANCED MODALITIES TO DRIVE MARKET
- 14.3 ACADEMIC & RESEARCH INSTITUTES
- 14.3.1 INCREASING FUNDING FOR GENOMIC PROJECTS TO PROPEL MARKET
- 14.4 OTHER END USERS
15 GENE EDITING MARKET, BY REGION
- 15.1 INTRODUCTION
- 15.2 NORTH AMERICA
- 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 15.2.2 US
- 15.2.2.1 Growing investments by government authorities and private players to drive market
- 15.2.3 CANADA
- 15.2.3.1 Rise in research & development initiatives for genomics and biotechnology to augment growth
- 15.3 EUROPE
- 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 15.3.2 GERMANY
- 15.3.2.1 Growing focus on promoting innovations in biotechnology sector to boost market
- 15.3.3 FRANCE
- 15.3.3.1 Ongoing clinical trials and advanced genomic research to promote growth
- 15.3.4 UK
- 15.3.4.1 Growing focus on developing cell and gene therapy infrastructure to fuel market
- 15.3.5 ITALY
- 15.3.5.1 Increasing availability of research funds to expedite growth
- 15.3.6 SPAIN
- 15.3.6.1 Booming biotechnology sector to contribute to market growth
- 15.3.7 REST OF EUROPE
- 15.4 ASIA PACIFIC
- 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 15.4.2 CHINA
- 15.4.2.1 Increasing affordability of sequencing platforms and procedures to favor growth
- 15.4.3 JAPAN
- 15.4.3.1 Growing focus on cancer research to fuel market
- 15.4.4 INDIA
- 15.4.4.1 Increased awareness about therapeutic benefits of genome engineering to encourage growth
- 15.4.5 SOUTH KOREA
- 15.4.5.1 Rising inclination toward in vivo gene editing to stimulate growth
- 15.4.6 AUSTRALIA
- 15.4.6.1 Favorable regulatory landscape to sustain growth
- 15.4.7 REST OF ASIA PACIFIC
- 15.5 LATIN AMERICA
- 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 15.5.2 BRAZIL
- 15.5.2.1 Supportive regulatory framework for biotechnology innovation to fuel market
- 15.5.3 REST OF LATIN AMERICA
- 15.6 MIDDLE EAST
- 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
- 15.6.2 GCC COUNTRIES
- 15.6.2.1 Kingdom of Saudi Arabia
- 15.6.2.1.1 Increasing establishment of biotech startups to support market growth
- 15.6.2.2 United Arab Emirates (UAE)
- 15.6.2.2.1 Growing collaborations for genome sequencing to drive market
- 15.6.2.3 Other GCC Countries
- 15.6.2.1 Kingdom of Saudi Arabia
- 15.6.3 REST OF MIDDLE EAST
- 15.7 AFRICA
- 15.7.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
- 15.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
16 COMPETITIVE LANDSCAPE
- 16.1 INTRODUCTION
- 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
- 16.3 REVENUE ANALYSIS, 2019-2023
- 16.4 MARKET SHARE ANALYSIS, 2023
- 16.4.1 RANKING OF KEY MARKET PLAYERS
- 16.5 COMPANY VALUATION AND FINANCIAL METRICS
- 16.5.1 COMPANY VALUATION
- 16.5.2 FINANCIAL METRICS
- 16.6 BRAND/PRODUCT COMPARISON
- 16.6.1 THERMO FISHER SCIENTIFIC INC. (US)
- 16.6.2 MERCK KGAA (GERMANY)
- 16.6.3 GENSCRIPT (US)
- 16.6.4 AGILENT TECHNOLOGIES, INC. (US)
- 16.6.5 REVVITY, INC. (US)
- 16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 16.7.1 STARS
- 16.7.2 EMERGING LEADERS
- 16.7.3 PERVASIVE PLAYERS
- 16.7.4 PARTICIPANTS
- 16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 16.7.5.1 Company footprint
- 16.7.5.2 Product footprint
- 16.7.5.3 Service footprint
- 16.7.5.4 Technology footprint
- 16.7.5.5 Region footprint
- 16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 16.8.1 PROGRESSIVE COMPANIES
- 16.8.2 RESPONSIVE COMPANIES
- 16.8.3 DYNAMIC COMPANIES
- 16.8.4 STARTING BLOCKS
- 16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 16.8.5.1 Detailed list of key startups/SMEs
- 16.8.5.2 Competitive benchmarking of key startups/SMEs
- 16.9 COMPETITIVE SCENARIO
- 16.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
- 16.9.2 DEALS
- 16.9.3 EXPANSIONS
17 COMPANY PROFILES
- 17.1 KEY PLAYERS
- 17.1.1 THERMO FISHER SCIENTIFIC INC.
- 17.1.1.1 Business overview
- 17.1.1.2 Products/Services offered
- 17.1.1.3 Recent developments
- 17.1.1.3.1 Product/Service launches & approvals
- 17.1.1.3.2 Deals
- 17.1.1.3.3 Expansions
- 17.1.1.4 MnM view
- 17.1.1.4.1 Key strengths
- 17.1.1.4.2 Strategic choices
- 17.1.1.4.3 Weaknesses & competitive threats
- 17.1.2 MERCK KGAA
- 17.1.2.1 Business overview
- 17.1.2.2 Products/Services offered
- 17.1.2.3 Recent developments
- 17.1.2.3.1 Deals
- 17.1.2.4 MnM view
- 17.1.2.4.1 Key strengths
- 17.1.2.4.2 Strategic choices
- 17.1.2.4.3 Weaknesses & competitive threats
- 17.1.3 GENSCRIPT
- 17.1.3.1 Business overview
- 17.1.3.2 Products/Services offered
- 17.1.3.3 Recent developments
- 17.1.3.3.1 Product/Service launches & approvals
- 17.1.3.3.2 Deals
- 17.1.3.3.3 Expansions
- 17.1.3.4 MnM view
- 17.1.3.4.1 Key strengths
- 17.1.3.4.2 Strategic choices
- 17.1.3.4.3 Weaknesses and competitive threats
- 17.1.4 AGILENT TECHNOLOGIES, INC.
- 17.1.4.1 Business overview
- 17.1.4.2 Products/Services offered
- 17.1.4.3 Recent developments
- 17.1.4.3.1 Deals
- 17.1.4.3.2 Expansions
- 17.1.4.4 MnM view
- 17.1.4.4.1 Key strengths
- 17.1.4.4.2 Strategic choices
- 17.1.4.4.3 Weaknesses & competitive threats
- 17.1.5 REVVITY, INC.
- 17.1.5.1 Business overview
- 17.1.5.2 Products/Services offered
- 17.1.5.3 Recent developments
- 17.1.5.3.1 Product/Service launches
- 17.1.5.3.2 Deals
- 17.1.5.4 MnM view
- 17.1.5.4.1 Key strengths
- 17.1.5.4.2 Strategic choices
- 17.1.5.4.3 Weakness & competitive threats
- 17.1.6 LONZA
- 17.1.6.1 Business overview
- 17.1.6.2 Products/Services offered
- 17.1.6.3 Recent developments
- 17.1.6.3.1 Product/Service launches
- 17.1.7 TECAN TRADING AG
- 17.1.7.1 Business overview
- 17.1.7.2 Products/Services offered
- 17.1.7.3 Recent developments
- 17.1.7.3.1 Deals
- 17.1.8 SANGAMO THERAPEUTICS
- 17.1.8.1 Business overview
- 17.1.8.2 Products/Services offered
- 17.1.8.3 Recent developments
- 17.1.8.3.1 Deals
- 17.1.9 PRECISION BIOSCIENCES
- 17.1.9.1 Business overview
- 17.1.9.2 Products/Services offered
- 17.1.9.3 Recent developments
- 17.1.9.3.1 Deals
- 17.1.10 CELLECTIS S.A.
- 17.1.10.1 Business overview
- 17.1.10.2 Products/Services offered
- 17.1.10.3 Recent developments
- 17.1.10.3.1 Deals
- 17.1.11 REGENERON PHARMACEUTICALS, INC.
- 17.1.11.1 Business overview
- 17.1.11.2 Products/Services offered
- 17.1.11.3 Recent developments
- 17.1.11.3.1 Deals
- 17.1.12 AMSBIO
- 17.1.12.1 Business overview
- 17.1.12.2 Products/Services offered
- 17.1.13 CREATIVE BIOGENE
- 17.1.13.1 Business overview
- 17.1.13.2 Products/Services offered
- 17.1.14 SYNTHEGO
- 17.1.14.1 Business overview
- 17.1.14.2 Products/Services offered
- 17.1.14.3 Recent developments
- 17.1.14.3.1 Product/Service launches
- 17.1.14.3.2 Deals
- 17.1.14.3.3 Expansions
- 17.1.15 TAKARA BIO INC.
- 17.1.15.1 Business overview
- 17.1.15.2 Products/Services offered
- 17.1.15.3 Recent developments
- 17.1.15.3.1 Deals
- 17.1.15.3.2 Expansions
- 17.1.16 BIO-TECHNE
- 17.1.16.1 Business overview
- 17.1.16.2 Products/Services offered
- 17.1.16.3 Recent developments
- 17.1.16.3.1 Deals
- 17.1.16.3.2 Expansions
- 17.1.17 CARIBOU BIOSCIENCES, INC.
- 17.1.17.1 Business overview
- 17.1.17.2 Products/Services offered
- 17.1.17.3 Recent developments
- 17.1.17.3.1 Deals
- 17.1.18 BIONEER CORPORATION
- 17.1.18.1 Business overview
- 17.1.18.2 Products/Services offered
- 17.1.19 REPROCELL INC.
- 17.1.19.1 Business overview
- 17.1.19.2 Products/Services offered
- 17.1.1 THERMO FISHER SCIENTIFIC INC.
- 17.2 OTHER PLAYERS
- 17.2.1 ALSTEM INC.
- 17.2.2 NEW ENGLAND BIOLABS
- 17.2.3 INSCRIPTA, INC.
- 17.2.4 BIOCAT GMBH.
- 17.2.5 INTEGRATED DNA TECHNOLOGIES, INC.
- 17.2.6 COBO TECHNOLOGIES APS
- 17.2.7 GENECOPOEIA, INC.
- 17.2.8 HERA BIOLABS
- 17.2.9 STEMCELL TECHNOLOGIES.
- 17.2.10 AXOL BIOSCIENCE LTD.
- 17.2.11 CELLECTA, INC.
- 17.2.12 APPLIED STEMCELL
18 APPENDIX
- 18.1 DISCUSSION GUIDE
- 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 18.3 CUSTOMIZATION OPTIONS
- 18.4 RELATED REPORTS
- 18.5 AUTHOR DETAILS
List of Tables
- TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
- TABLE 2 GENE EDITING MARKET: RISK ASSESSMENT ANALYSIS
- TABLE 3 GENE EDITING MARKET: IMPACT ANALYSIS
- TABLE 4 APPROVALS FOR PERSONALIZED MEDICINE (GENE THERAPIES), 2023-2024
- TABLE 5 PERSONALIZED MEDICINE APPROVALS (GENE THERAPIES) IN 2022
- TABLE 6 AVERAGE COST RANGE OF GENE EDITING KITS & REAGENTS, 2021-2023
- TABLE 7 AVERAGE SELLING PRICE, BY REGION, 2021-2023 (USD)
- TABLE 8 COMMERCIALIZATION OF AI IN GENE EDITING
- TABLE 9 GENE EDITING MARKET: KEY CONFERENCES & EVENTS, 2024-2025
- TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 11 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 12 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 14 GENE EDITING MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 15 GENE EDITING MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
- TABLE 16 INVESTMENT & FUNDING ACTIVITIES, BY KEY PLAYER (2021-2024)
- TABLE 17 IMPORT DATA FOR KITS & REAGENTS, BY REGION, 2019-2023 (USD)
- TABLE 18 EXPORT DATA FOR KITS & REAGENTS, BY REGION, 2019-2023 (USD THOUSAND)
- TABLE 19 GENE EDITING MARKET, BY OFFERING, 2022-2029 (USD MILLION)
- TABLE 20 GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 21 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 22 EUROPE: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 23 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 24 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 25 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 26 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 27 GENE EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 28 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 29 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 30 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 31 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 32 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 33 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 34 GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 35 GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 36 GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 37 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 38 EUROPE: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 39 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 40 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 41 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 42 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 43 GENE EDITING KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 44 NORTH AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 45 EUROPE: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 46 ASIA PACIFIC: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 47 LATIN AMERICA: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 48 MIDDLE EAST: GENE EDITING KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 49 GCC COUNTRIES: GENE EDITING KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 50 GENE EDITING LIBRARIES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 51 NORTH AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 52 EUROPE: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 53 ASIA PACIFIC: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 54 LATIN AMERICA: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 55 MIDDLE EAST: GENE EDITING LIBRARIES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 56 GCC COUNTRIES: GENE EDITING LIBRARIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 57 GENE EDITING REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 58 NORTH AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 59 EUROPE: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 60 ASIA PACIFIC: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 61 LATIN AMERICA: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 62 MIDDLE EAST: GENE EDITING REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 63 GCC COUNTRIES: GENE EDITING REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 64 GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 65 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 66 EUROPE: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 67 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 68 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 69 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 70 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR SOFTWARE & SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 71 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 72 KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 73 NORTH AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 74 EUROPE: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 75 ASIA PACIFIC: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 76 LATIN AMERICA: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 77 MIDDLE EAST: KNOCK-OUT TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 78 GCC COUNTRIES: KNOCK-OUT TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 79 KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 80 NORTH AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 81 EUROPE: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 82 ASIA PACIFIC: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 83 LATIN AMERICA: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 84 MIDDLE EAST: KNOCK-IN TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 85 GCC COUNTRIES: KNOCK-IN TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 86 GENE SILENCING TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 87 NORTH AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 88 EUROPE: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 89 ASIA PACIFIC: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 90 LATIN AMERICA: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 91 MIDDLE EAST: GENE SILENCING TECHNIQUE MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 92 GCC COUNTRIES: GENE SILENCING TECHNIQUE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 93 OTHER TECHNIQUES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 94 NORTH AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 95 EUROPE: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 96 ASIA PACIFIC: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 97 LATIN AMERICA: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 98 MIDDLE EAST: OTHER TECHNIQUES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 99 GCC COUNTRIES: OTHER TECHNIQUES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 100 GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 101 GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022-2029 (USD MILLION)
- TABLE 102 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 103 EUROPE: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 104 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 105 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 106 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY REGION, 2022-2029 (USD MILLION)
- TABLE 107 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CRISPR, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 108 GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2022-2029 (USD MILLION)
- TABLE 109 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 110 EUROPE: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 111 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 112 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 113 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR TALEN, BY REGION, 2022-2029 (USD MILLION)
- TABLE 114 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR TALEN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 115 GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2022-2029 (USD MILLION)
- TABLE 116 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 117 EUROPE: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 118 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 119 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 120 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ZFN, BY REGION, 2022-2029 (USD MILLION)
- TABLE 121 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ZFN, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 122 GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 123 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 124 EUROPE: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 125 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 126 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 127 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY REGION, 2022-2029 (USD MILLION)
- TABLE 128 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR BASE EDITING, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 129 GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022-2029 (USD MILLION)
- TABLE 130 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 131 EUROPE: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 132 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 133 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 134 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY REGION, 2022-2029 (USD MILLION)
- TABLE 135 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ANTISENSE, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 136 GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2022-2029 (USD MILLION)
- TABLE 137 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 138 EUROPE: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 139 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 140 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 141 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR RNAI, BY REGION, 2022-2029 (USD MILLION)
- TABLE 142 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR RNAI, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 143 GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 144 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 145 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 146 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 147 LATIN AMERICA: GENE EDITING GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 148 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 149 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 150 GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 151 CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 152 NORTH AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 153 EUROPE: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 154 ASIA PACIFIC: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 155 LATIN AMERICA: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 156 MIDDLE EAST: CELL LINE ENGINEERING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 157 GCC COUNTRIES: CELL LINE ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 158 GENOME EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 159 NORTH AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 160 EUROPE: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 161 ASIA PACIFIC: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 162 LATIN AMERICA: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 163 MIDDLE EAST: GENOME EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 164 GCC COUNTRIES: GENOME EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 165 DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 166 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 167 EUROPE: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 168 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 169 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 170 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 171 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION) (USD MILLION)
- TABLE 172 GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 173 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 174 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 175 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 176 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 177 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 178 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 179 GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 180 GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 181 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 182 EUROPE: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 183 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 184 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 185 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 186 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 187 GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 188 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 189 EUROPE: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 190 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 191 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 192 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 193 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 194 GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 195 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 196 EUROPE: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 197 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 198 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 199 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 200 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR CROS & CDMOS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 201 GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 202 NORTH AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 203 EUROPE: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 204 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 205 LATIN AMERICA: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 206 MIDDLE EAST: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 207 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 208 GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 209 CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 210 NORTH AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 211 EUROPE: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 212 ASIA PACIFIC: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 213 LATIN AMERICA: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 214 MIDDLE EAST: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 215 GCC COUNTRIES: CELL LINE DEVELOPMENT & ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 216 GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 217 NORTH AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 218 EUROPE: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 219 ASIA PACIFIC: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 220 LATIN AMERICA: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 221 MIDDLE EAST: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 222 GCC COUNTRIES: GRNA SYNTHESIS & VECTOR CONSTRUCTION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 223 LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 224 NORTH AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 225 EUROPE: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 226 ASIA PACIFIC: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 227 LATIN AMERICA: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 228 MIDDLE EAST: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 229 GCC COUNTRIES: LIBRARY CONSTRUCTION & SCREENING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 230 GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 231 NORTH AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 232 EUROPE: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 233 ASIA PACIFIC: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 234 LATIN AMERICA: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 235 MIDDLE EAST: GENE EDITING MARKET FOR OTHER SERVICES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 236 GCC COUNTRIES: GENE EDITING MARKET FOR OTHER SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 237 GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 238 CELL ENGINEERING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 239 NORTH AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 240 EUROPE: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 241 ASIA PACIFIC: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 242 LATIN AMERICA: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 243 MIDDLE EAST: CELL ENGINEERING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 244 GCC COUNTRIES: CELL ENGINEERING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 245 GENOME EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 246 NORTH AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 247 EUROPE: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 248 ASIA PACIFIC: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 249 LATIN AMERICA: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 250 MIDDLE EAST: GENOME EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 251 GCC COUNTRIES: GENOME EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 252 DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 253 NORTH AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 254 EUROPE: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 255 ASIA PACIFIC: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 256 LATIN AMERICA: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 257 MIDDLE EAST: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 258 GCC COUNTRIES: DRUG DISCOVERY & DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 259 GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 260 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 261 EUROPE: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 262 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 263 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 264 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 265 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 266 GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 267 GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 268 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 269 EUROPE: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 270 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 271 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 272 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 273 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 274 GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 275 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 276 EUROPE: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 277 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 278 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 279 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
- TABLE 280 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 281 GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 282 NORTH AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 283 EUROPE: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 284 ASIA PACIFIC: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 285 LATIN AMERICA: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 286 MIDDLE EAST: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
- TABLE 287 GCC COUNTRIES: GENE EDITING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 288 GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 289 GENE EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 290 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 291 NORTH AMERICA GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 292 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 293 NORTH AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 294 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 295 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 296 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 297 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 298 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 299 NORTH AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 300 NORTH AMERICA: MACROECONOMIC INDICATORS
- TABLE 301 US: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 302 US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 303 US: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 304 US: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 305 US: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 306 US: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 307 US: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 308 US: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 309 US: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 310 CANADA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 311 CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 312 CANADA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 313 CANADA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 314 CANADA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 315 CANADA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 316 CANADA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 317 CANADA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 318 CANADA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 319 EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 320 EUROPE: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 321 EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 322 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 323 EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 324 EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 325 EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 326 EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 327 EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 328 EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 329 EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 330 EUROPE: MACROECONOMIC INDICATORS
- TABLE 331 GERMANY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 332 GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 333 GERMANY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 334 GERMANY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 335 GERMANY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 336 GERMANY: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 337 GERMANY: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 338 GERMANY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 339 GERMANY: GENE EDITING SERVICES MARKET, BY END USERS, 2022-2029 (USD MILLION)
- TABLE 340 FRANCE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 341 FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 342 FRANCE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 343 FRANCE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 344 FRANCE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 345 FRANCE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 346 FRANCE: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 347 FRANCE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 348 FRANCE: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 349 UK: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 350 UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 351 UK: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 352 UK: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 353 UK: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 354 UK: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 355 UK: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 356 UK: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 357 UK: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 358 ITALY: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 359 ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 360 ITALY: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 361 ITALY: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 362 ITALY: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 363 ITALY: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 364 ITALY: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 365 ITALY: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 366 ITALY: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 367 SPAIN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 368 SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 369 SPAIN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 370 SPAIN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 371 SPAIN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 372 SPAIN: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 373 SPAIN: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 374 SPAIN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 375 SPAIN: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 376 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 377 REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 378 REST OF EUROPE: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 379 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 380 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 381 REST OF EUROPE: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 382 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 383 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 384 REST OF EUROPE: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 385 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 386 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 387 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 388 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 389 ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 390 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 391 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 392 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 393 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 394 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 395 ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 396 ASIA PACIFIC: MACROECONOMIC INDICATORS
- TABLE 397 CHINA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 398 CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 399 CHINA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 400 CHINA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 401 CHINA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 402 CHINA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 403 CHINA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 404 CHINA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 405 CHINA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 406 JAPAN: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 407 JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 408 JAPAN: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 409 JAPAN: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 410 JAPAN: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 411 JAPAN: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 412 JAPAN: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 413 JAPAN: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 414 JAPAN: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 415 INDIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 416 INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 417 INDIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 418 INDIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 419 INDIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 420 INDIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 421 INDIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 422 INDIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 423 INDIA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 424 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 425 SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 426 SOUTH KOREA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 427 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 428 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 429 SOUTH KOREA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 430 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 431 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 432 SOUTH KOREA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 433 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 434 AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 435 AUSTRALIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 436 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 437 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 438 AUSTRALIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 439 AUSTRALIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 440 AUSTRALIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 441 AUSTRALIA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 442 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 443 REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 444 REST OF ASIA PACIFIC: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 445 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 446 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 447 REST OF ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 448 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 449 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 450 REST OF ASIA PACIFIC: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 451 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 452 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 453 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 454 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 455 LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 456 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 457 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 458 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 459 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 460 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 461 LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 462 LATIN AMERICA: MACROECONOMIC INDICATORS
- TABLE 463 BRAZIL: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 464 BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 465 BRAZIL: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 466 BRAZIL: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 467 BRAZIL: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 468 BRAZIL: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 469 BRAZIL: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 470 BRAZIL: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 471 BRAZIL: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 472 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 473 REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 474 REST OF LATIN AMERICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 475 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 476 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 477 REST OF LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 478 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 479 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 480 REST OF LATIN AMERICA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 481 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 482 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
- TABLE 483 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 484 MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 485 MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 486 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 487 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 488 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 489 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 490 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 491 MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 492 MIDDLE EAST: MACROECONOMIC INDICATORS
- TABLE 493 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 494 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
- TABLE 495 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 496 GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 497 GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 498 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 499 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 500 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 501 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 502 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 503 GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 504 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 505 KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 506 KINGDOM OF SAUDI ARABIA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 507 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 508 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 509 KINGDOM OF SAUDI ARABIA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 510 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 511 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 512 KINGDOM OF SAUDI ARABIA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 513 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 514 UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 515 UNITED ARAB EMIRATES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 516 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 517 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 518 UNITED ARAB EMIRATES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 519 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 520 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 521 UNITED ARAB EMIRATES: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 522 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 523 OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 524 OTHER GCC COUNTRIES: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 525 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 526 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 527 OTHER GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 528 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 529 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 530 OTHER GCC COUNTRIES: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 531 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 532 REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 533 REST OF MIDDLE EAST: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 534 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 535 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 536 REST OF MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 537 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 538 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 539 REST OF MIDDLE EAST: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 540 AFRICA: GENE EDITING PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 541 AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 542 AFRICA: GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2022-2029 (USD MILLION)
- TABLE 543 AFRICA: GENE EDITING PRODUCTS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
- TABLE 544 AFRICA: GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 545 AFRICA: GENE EDITING PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 546 AFRICA: GENE EDITING SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
- TABLE 547 AFRICA: GENE EDITING SERVICES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
- TABLE 548 AFRICA: GENE EDITING SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
- TABLE 549 MACROECONOMIC OUTLOOK FOR AFRICA
- TABLE 550 GENE EDITING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021-2024
- TABLE 551 GENE EDITING MARKET: DEGREE OF COMPETITION, 2023
- TABLE 552 GENE EDITING MARKET: PRODUCT FOOTPRINT
- TABLE 553 GENE EDITING MARKET: SERVICE FOOTPRINT
- TABLE 554 GENE EDITING MARKET: TECHNOLOGY FOOTPRINT
- TABLE 555 GENE EDITING MARKET: APPLICATION FOOTPRINT
- TABLE 556 GENE EDITING MARKET: REGION FOOTPRINT
- TABLE 557 GENE EDITING MARKET: KEY STARTUPS/SMES
- TABLE 558 GENE EDITING MARKET: COMPETITIVE BENCHMARKING OF KEY START UPS/SMES
- TABLE 559 GENE EDITING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 560 GENE EDITING MARKET: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 561 GENE EDITING MARKET: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
- TABLE 562 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 563 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
- TABLE 564 THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS/LAUNCHES, JANUARY 2021-SEPTEMBER 2024
- TABLE 565 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 566 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
- TABLE 567 MERCK KGAA: COMPANY OVERVIEW
- TABLE 568 MERCK KGAA.: PRODUCTS/SERVICES OFFERED
- TABLE 569 MERCK KGAA: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 570 GENSCRIPT: COMPANY OVERVIEW
- TABLE 571 GENSCRIPT.: PRODUCTS/SERVICES OFFERED
- TABLE 572 GENSCRIPT: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 573 GENSCRIPT: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 574 GENSCRIPT: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
- TABLE 575 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 576 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 577 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 578 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
- TABLE 579 REVVITY. INC. COMPANY OVERVIEW
- TABLE 580 REVVITY, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 581 REVIVTY, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
- TABLE 582 REVVITY, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 583 LONZA: COMPANY OVERVIEW
- TABLE 584 LONZA: PRODUCTS/SERVICES OFFERED
- TABLE 585 LONZA: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
- TABLE 586 TECAN TRADING AG: COMPANY OVERVIEW
- TABLE 587 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
- TABLE 588 TECAN TRADING AG: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 589 SANGAMO THERAPEUTICS: COMPANY OVERVIEW
- TABLE 590 SANGAMO THERAPEUTICS: PRODUCTS/SERVICES OFFERED
- TABLE 591 SANGAMO THERAPEUTICS: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 592 PRECISION BIOSCIENCES: COMPANY OVERVIEW
- TABLE 593 PRECISION BIOSCIENCES: PRODUCTS/SERVICES OFFERED
- TABLE 594 PRECISION BIOSCIENCES: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 595 CELLECTIS S.A.: COMPANY OVERVIEW
- TABLE 596 CELLECTIS S.A.: PRODUCTS/SERVICES OFFERED
- TABLE 597 CELLECTIS S.A.: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 598 REGENERON PHARMACEUTICALS, INC.: COMPANY OVERVIEW
- TABLE 599 REGENERON PHARMACEUTICALS INC.: PRODUCTS/SERVICES OFFERED
- TABLE 600 REGENERON PHARMACEUTICALS, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 601 AMSBIO: COMPANY OVERVIEW
- TABLE 602 AMSBIO: PRODUCTS/SERVICES OFFERED
- TABLE 603 CREATIVE BIOGENE: COMPANY OVERVIEW
- TABLE 604 CREATIVE BIOGENE: PRODUCTS/SERVICES OFFERED
- TABLE 605 SYNTHEGO: COMPANY OVERVIEW
- TABLE 606 SYNTHEGO: PRODUCTS/SERVICES OFFERED
- TABLE 607 SYNTHEGO: PRODUCT/SERVICE LAUNCHES, JANUARY 2021-SEPTEMBER 2024
- TABLE 608 SYNTHEGO: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 609 SYNTHEGO: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
- TABLE 610 TAKARA BIO INC.: COMPANY OVERVIEW
- TABLE 611 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED
- TABLE 612 TAKARA BIO INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 613 TAKARA BIO, INC.: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
- TABLE 614 BIO-TECHNE: COMPANY OVERVIEW
- TABLE 615 BIO-TECHNE.: PRODUCTS/SERVICES OFFERED
- TABLE 616 BIO-TECHNE: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 617 BIO-TECHNE: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
- TABLE 618 CARIBOU BIOSCIENCES, INC.: COMPANY OVERVIEW
- TABLE 619 CARIBOU BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 620 CARIBOU BIOSCIENCES, INC.: DEALS, JANUARY 2021-SEPTEMBER 2024
- TABLE 621 BIONEER CORPORATION: COMPANY OVERVIEW
- TABLE 622 BIONEER CORPORATION: PRODUCTS/SERVICES OFFERED
- TABLE 623 REPROCELL, INC.: COMPANY OVERVIEW
- TABLE 624 REPROCELL, INC.: PRODUCTS/SERVICES OFFERED
- TABLE 625 ALSTEM INC.: COMPANY OVERVIEW
- TABLE 626 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
- TABLE 627 INSCRIPTA, INC.: COMPANY OVERVIEW
- TABLE 628 BIOCAT GMBH: COMPANY OVERVIEW
- TABLE 629 INTEGRATED DNA TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 630 COBO TECHNOLOGIES APS.: COMPANY OVERVIEW
- TABLE 631 GENECOPOEIA, INC.: COMPANY OVERVIEW
- TABLE 632 HERA BIOLABS: COMPANY OVERVIEW
- TABLE 633 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
- TABLE 634 AXOL BIOSCIENCE LTD.: COMPANY OVERVIEW
- TABLE 635 CELLECTA, INC.: COMPANY OVERVIEW
- TABLE 636 APPLIED STEMCELL: COMPANY OVERVIEW
List of Figures
- FIGURE 1 RESEARCH DESIGN
- FIGURE 2 GENE EDITING MARKET: BREAKDOWN OF PRIMARIES
- FIGURE 3 GENE EDITING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
- FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
- FIGURE 5 ILLUSTRATIVE EXAMPLE OF AGILENT TECHNOLOGIES, INC.: REVENUE SHARE ANALYSIS (2023)
- FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
- FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
- FIGURE 8 GENE EDITING MARKET: CAGR PROJECTIONS
- FIGURE 9 DATA TRIANGULATION METHODOLOGY
- FIGURE 10 GENE EDITING MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
- FIGURE 11 GENE EDITING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
- FIGURE 12 GENE EDITING REAGENTS & CONSUMABLES MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)
- FIGURE 13 GENE EDITING PRODUCTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
- FIGURE 14 GENE EDITING PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
- FIGURE 15 GENE EDITING SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
- FIGURE 16 GENE EDITING SERVICES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
- FIGURE 17 GENE EDITING SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
- FIGURE 18 GEOGRAPHIC SNAPSHOT OF GENE EDITING MARKET
- FIGURE 19 INCREASING DEMAND FOR PERSONALIZED MEDICINE AND EXPANDING APPLICATIONS OF GENE EDITING TO DRIVE MARKET
- FIGURE 20 REAGENTS & CONSUMABLES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN US IN 2023
- FIGURE 21 CELL LINE ENGINEERING TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
- FIGURE 22 GENE EDITING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 23 GOVERNMENT FUNDING FOR GENE EDITING PROJECTS, 2019-2023 (USD MILLION)
- FIGURE 24 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- FIGURE 25 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY CONSUMABLES (2023)
- FIGURE 26 AVERAGE SELLING PRICE TREND OF SERVICES, BY TYPE
- FIGURE 27 AVERAGE SELLING PRICE, BY REGION, 2023 (USD)
- FIGURE 28 GENE EDITING MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 29 GENE EDITING MARKET: VALUE CHAIN ANALYSIS
- FIGURE 30 GENE EDITING MARKET: TRANSFECTION & SCREENING TO ADD MAXIMUM VALUE TO WORKFLOW
- FIGURE 31 GENE EDITING MARKET: ECOSYSTEM ANALYSIS
- FIGURE 32 IMPACT OF AI/GEN AI IN GENE EDITING MARKET
- FIGURE 33 PATENT APPLICATIONS FOR GENE EDITING (JANUARY 2013-DECEMBER 2023)
- FIGURE 34 GENE EDITING MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
- FIGURE 36 KEY BUYING CRITERIA OF END USERS, BY PRODUCT
- FIGURE 37 KEY BUYING CRITERIA OF END USERS, BY SERVICES
- FIGURE 38 NIH FUNDING FOR GENE EDITING PROJECTS
- FIGURE 39 NORTH AMERICA: GENE EDITING MARKET SNAPSHOT
- FIGURE 40 ASIA PACIFIC: GENE EDITING MARKET SNAPSHOT
- FIGURE 41 GENE EDITING MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023
- FIGURE 42 MARKET SHARE ANALYSIS OF GENE EDITING MARKET, 2023
- FIGURE 43 RANKING OF KEY PLAYERS IN GENE EDITING MARKET, 2023
- FIGURE 44 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 45 EV/EBITDA OF KEY PLAYERS
- FIGURE 46 GENE EDITING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 47 GENE EDITING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- FIGURE 48 GENE EDITING MARKET: COMPANY FOOTPRINT
- FIGURE 49 GENE EDITING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
- FIGURE 50 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
- FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT (2023)
- FIGURE 52 GENSCRIPT: COMPANY SNAPSHOT (2023)
- FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 54 REVVITY, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 55 LONZA: COMPANY SNAPSHOT (2023)
- FIGURE 56 TECAN TRADING AG: COMPANY SNAPSHOT (2023)
- FIGURE 57 SANGAMO THERAPEUTICS: COMPANY SNAPSHOT (2023)
- FIGURE 58 PRECISION BIOSCIENCES: COMPANY SNAPSHOT (2023)
- FIGURE 59 CELLECTIS S.A.: COMPANY SNAPSHOT (2023)
- FIGURE 60 REGENERON PHARMACEUTICALS INC.: COMPANY SNAPSHOT (2023)
- FIGURE 61 TAKARA BIO INC.: COMPANY SNAPSHOT (2023)
- FIGURE 62 BIO-TECHNE: COMPANY SNAPSHOT (2023)
- FIGURE 63 CARIBOU BIOSCIENCES, INC.: COMPANY SNAPSHOT (2023)
- FIGURE 64 BIONEER CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 65 REPROCELL, INC.: COMPANY SNAPSHOT (2023)
02-2729-4219
+886-2-2729-4219
基因编辑联盟和许可协议：2016-2024
基因改造食品市场：按类型、特征、加工和最终用户划分 - 全球预测 2025-2030
基因编辑市场：按技术、应用、最终用户、产品和服务、交付方式分类 - 2025-2030 年全球预测
基因编辑治疗的全球市场
基因改造食品安全检测市场，按性状测试、技术、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测
基因编辑市场 - 全球产业规模、份额、趋势、机会和预测，按产品和服务、技术、应用、最终用户、地区和竞争细分，2019-2029F
亚太基因编辑技术市场：分析与预测（2023-2032）
欧洲基因编辑技术市场：分析与预测，2023-2032
基因编辑技术市场：按产品、技术、应用、最终用户划分 - 2024-2030 年全球预测
基因编辑市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按组件、技术、应用、最终用户和地理位置
▼